American Cancer Society

[1] American Cancer Society. Cancer facts and figures 2007. Last accessed April 10, 2007 [http://www.cancer.org/docroot/stt/stt_0.asp]
[2] Carroll PR, Nelson GW. Report to the Nation on Prostate Cancer 2004.Last accessed April 10, 2007 [http://www.medscape.comviewarticle/489635]
[3] Sternberg CN, Krainer M, Oh WK, Barcarda S, et al. The medical management of prostate cancer: a multidisciplinary team approach. BJU International 2007 (Jan) 99; 1, 22?27 [http://www.ncbi.nlm.nih.gov/pubmed/16956362]
[4] Carducci MA, Carroll PR. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Urology. 2005 (May); 65(5 Suppl):18-22; discussion 22. Last Accessed April 10, 2007 [http://www.goldjournal.net/article/PIIS0090429505003560/fulltext][http://www.ncbi.nlm.nih.gov/pubmed/15885275]
[5] Dogliotti L. European Urology ? Advanced Prostate Cancer: At last a role for medical Oncologists. UroToday, 2007 (Jan) 51, 1, 4-5. [http://www.ncbi.nlm.nih.gov/pubmed/17000045]
[6] Taneja, SS. A Multidisciplinary approach to the Management of Hormone-Refractory Prostate Cancer. Rev Urol 2003; 5 (Suppl 2): S53-S59 [http://www.ncbi.nlm.nih.gov/pubmed/16986048]
[7] Saad F, Sternberg CN. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy. Nat Clin Pract Urol. 2007 Feb; 4 Suppl 1: S3-13. [http://www.ncbi.nlm.nih.gov/pubmed/17264863]
[8] World Health Organisation (1990) Cancer pain relief and palliative care. WHO Technical report series, 804. WHO Geneva, Switzerland.
[9] Arcangeli G, Giovinazzo G, Saracino B, et al Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncology Biol Phys. 1998;42:1119-1126. [http://www.ncbi.nlm.nih.gov/pubmed/9869238]
[10] Chow E. Danjoux C, Wong R, et al. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol. 2000; 56: 3005-314. [http://www.ncbi.nlm.nih.gov/pubmed/10974379]
[11]Carducci MA. What is More Exciting? The Activity of Docetaxel in Early Prostate Cancer or Successful Collaboration Between Urologists and Medical Oncologists to Complete a Study in Early Prostate Cancer? J Clin Onc. 2005, 23;15 (May 20), 3304-3307 [http://www.ncbi.nlm.nih.gov/pubmed/15738547]